Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Influence of nutrition support therapy on readmission among patients with acute heart failure in the intensive care unit: A single-center observational study.

Miyajima I, Yatabe T, Kuroiwa H, Tamura T, Yokoyama M.

Clin Nutr. 2019 Jan 22. pii: S0261-5614(19)30012-3. doi: 10.1016/j.clnu.2019.01.010. [Epub ahead of print]

PMID:
30704891
2.

Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.

Kawaguchi T, Ide T, Koga H, Kondo R, Miyajima I, Arinaga-Hino T, Kuwahara R, Amano K, Niizeki T, Nakano M, Kuromatsu R, Torimura T.

Clin J Gastroenterol. 2018 Feb;11(1):69-74. doi: 10.1007/s12328-017-0789-1. Epub 2017 Oct 29.

PMID:
29082453
3.

Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan.

Arinaga-Hino T, Ide T, Miyajima I, Ogata K, Kuwahara R, Amano K, Kawaguchi T, Nakamura T, Kawaguchi T, Koga H, Yonemoto K, Torimura T; Kurume Autoimmune Hepatitis Study Group.

Hepatol Res. 2018 Feb;48(3):E222-E231. doi: 10.1111/hepr.12973. Epub 2017 Sep 28.

PMID:
28841782
4.

Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.

Ide T, Eguchi Y, Harada M, Ishii K, Morita M, Morita Y, Sugiyama G, Fukushima H, Yano Y, Noguchi K, Nakamura H, Hisatomi J, Kumemura H, Shirachi M, Iwane S, Okada M, Honma Y, Arinaga-Hino T, Miyajima I, Ogata K, Kuwahara R, Amano K, Kawaguchi T, Kuromatsu R, Torimura T; DAAs Multicenter Study Group.

PLoS One. 2016 Sep 29;11(9):e0163884. doi: 10.1371/journal.pone.0163884. eCollection 2016.

5.

[Recurrent hepatocellular carcinoma and adrenal metastasis without intrahepatic metastasis detected 22 years after hepatic resection: a case report].

Kawaguchi T, Miyajima I, Kaji R, Sakakibara S, Fushimi T, Mori A, Miyahara K, Maekawa R, Yano H, Torimura T.

Nihon Shokakibyo Gakkai Zasshi. 2015 Dec;112(12):2176-82. doi: 10.11405/nisshoshi.112.2176. Japanese.

PMID:
26638790
6.

An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.

Hisamochi A, Kage M, Ide T, Arinaga-Hino T, Amano K, Kuwahara R, Ogata K, Miyajima I, Kumashiro R, Sata M, Torimura T.

J Gastroenterol. 2016 Jun;51(6):597-607. doi: 10.1007/s00535-015-1131-7. Epub 2015 Oct 30.

PMID:
26519284
7.

Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Amano K, Kawaguchi T, Kuromatsu R, Kawaguchi A, Miyajima I, Ide T, Kakuma T, Sata M.

Mol Clin Oncol. 2014 Nov;2(6):927-934. Epub 2014 Aug 21.

8.

Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis.

Hisamochi A, Kage M, Arinaga T, Ide T, Miyajima I, Ogata K, Kuwahara R, Koga Y, Kumashiro R, Sata M.

Clin J Gastroenterol. 2013 Apr;6(2):139-44. doi: 10.1007/s12328-013-0359-0. Epub 2013 Feb 5.

PMID:
26181451
9.

Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area.

Miyajima I, Kawaguchi T, Fukami A, Nagao Y, Adachi H, Sasaki S, Imaizumi T, Sata M.

J Gastroenterol. 2013 Jan;48(1):93-100. doi: 10.1007/s00535-012-0610-3. Epub 2012 Jun 8.

PMID:
22678465
10.

The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.

Kuhara K, Ide T, Uchimura N, Kumashiro R, Arinaga T, Miyajima I, Murashima S, Ogata K, Kuwahara R, Amano K, Fujimoto Y, Sakai K, Ishii K, Morita Y, Shirachi M, Sata M.

Kurume Med J. 2012;59(3-4):39-44.

11.

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.

Hino-Arinaga T, Ide T, Kuromatsu R, Miyajima I, Ogata K, Kuwahara R, Hisamochi A, Torimura T, Sata M; Autoimmune Hepatitis Study Group.

J Gastroenterol. 2012 May;47(5):569-76. doi: 10.1007/s00535-011-0519-2. Epub 2011 Dec 21.

PMID:
22187167
12.

[Lamivudine, adefovir dipivoxil].

Miyajima I, Sata M.

Nihon Rinsho. 2011 May;69 Suppl 4:492-7. Review. Japanese. No abstract available.

PMID:
22096967
13.

A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C.

Ide T, Hino T, Ogata K, Miyajima I, Kuwahara R, Kuhara K, Sata M.

Am J Gastroenterol. 2009 Jan;104(1):70-5. doi: 10.1038/ajg.2008.60.

PMID:
19098852
14.

Major anthocyanins from purple asparagus (Asparagus officinalis).

Sakaguchi Y, Ozaki Y, Miyajima I, Yamaguchi M, Fukui Y, Iwasa K, Motoki S, Suzuki T, Okubo H.

Phytochemistry. 2008 May;69(8):1763-6. doi: 10.1016/j.phytochem.2008.02.021. Epub 2008 Apr 10.

PMID:
18406435
15.

Immune sensitization in the skin is enhanced by antigen-independent effects of IgE on mast cells.

Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC.

Novartis Found Symp. 2005;271:15-24; discussion 24-38, 95-9.

PMID:
16605126
16.

Immune sensitization in the skin is enhanced by antigen-independent effects of IgE.

Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC.

Immunity. 2004 Apr;20(4):381-92.

17.

Morphology and phylogenetic position of a mat-forming green plant from acidic rivers in Japan.

Higuchi S, Kawamura M, Miyajima I, Akiyama H, Kosuge K, Kato M, Nozaki H.

J Plant Res. 2003 Dec;116(6):461-7. Epub 2003 Nov 7.

PMID:
14605911
18.

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

Kumashiro R, Ide T, Sasaki M, Murashima S, Suzuki H, Hino T, Morita Y, Miyajima I, Ogata K, Tanaka E, Yoshida H, Tanikawa K, Sata M.

Hepatol Res. 2002 Jan;22(1):20-26.

PMID:
11804830
19.

Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients.

Murashima S, Kumashiro R, Ide T, Miyajima I, Hino T, Koga Y, Ishii K, Ueno T, Sakisaka S, Sata M.

J Med Virol. 2000 Oct;62(2):185-90.

PMID:
11002247
20.

Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis.

Murashima S, Ide T, Miyajima I, Kumashiro R, Ueno T, Sakisaka S, Sata M.

Scand J Infect Dis. 1999;31(1):27-32.

PMID:
10381214
21.

Intraspousal transmission of GB virus C/hepatitis G virus in an hepatitis C virus hyperendemic area in Japan.

Akiyoshi F, Sata M, Noguchi S, Suzuki H, Ide T, Uchimura Y, Sasaki M, Tanaka K, Miyajima I, Mizokami M, Tanikawa K.

Am J Gastroenterol. 1999 Jun;94(6):1627-31.

PMID:
10364035
22.

Liver-associated natural killer activity in cirrhotic rats.

Shirachi M, Sata M, Miyajima I, Tanaka M, Tanikawa K.

Microbiol Immunol. 1998;42(2):117-24.

23.

The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment.

Miyajima I, Sata M, Kumashiro R, Uchimura Y, Ide T, Suzuki H, Tanikawa K.

Oncol Rep. 1998 Jan-Feb;5(1):201-4.

PMID:
9458322
24.

IgE regulates mouse basophil Fc epsilon RI expression in vivo.

Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ.

J Immunol. 1997 Mar 15;158(6):2517-21.

PMID:
9058781
27.

IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions.

Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ.

J Exp Med. 1997 Feb 17;185(4):663-72.

28.

Prevalence of hepatitis C antibodies in health care personnel.

Miyajima I, Sata M, Murashima S, Suzuki H, Kondo S, Ito Y, Kawano H, Tanikawa K.

Kansenshogaku Zasshi. 1997 Feb;71(2):103-7.

PMID:
9077066
29.

Sequential interferon-alpha and beta treatment in patients with chronic hepatitis C.

Miyajima I, Sata M, Uchimura Y, Ide T, Suzuki H, Tanikawa K.

Kansenshogaku Zasshi. 1996 Jul;70(7):690-5.

PMID:
8797303
30.

Evaluation of interferon treatment in cirrhotic patients with hepatitis C.

Ide T, Sata M, Suzuki H, Murashima S, Miyajima I, Shirachi M, Tanikawa K.

Kansenshogaku Zasshi. 1996 Jun;70(6):597-604.

PMID:
8741709
31.

Interferon accumulation in cirrhotic rat liver.

Miyajima I, Sata M, Gondo K, Suzuki H, Tanikawa K.

J Viral Hepat. 1996 Jan;3(1):23-7.

PMID:
8736237
32.

Decrease of interferon-induced 2',5'-oligoadenylate synthetase activity in cirrhotic rat liver.

Miyajima I, Sata M, Uchimura Y, Suzuki H, Tanikawa K.

Kansenshogaku Zasshi. 1995 Dec;69(12):1383-8.

PMID:
8586891
33.

The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promoter function.

Miyajima I, Levitt L, Hara T, Bedell MA, Copeland NG, Jenkins NA, Miyajima A.

Blood. 1995 Mar 1;85(5):1246-53.

34.

Somatic embryogenesis ofCyclamen persicum Mill. 'Anneke' from aseptic seedlings.

Takamura T, Miyajima I, Matsuo E.

Plant Cell Rep. 1995 Jan;15(1-2):22-5. doi: 10.1007/BF01690246.

PMID:
24185647
35.

Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor beta subunit (beta IL3).

Sakamaki K, Wang HM, Miyajima I, Kitamura T, Todokoro K, Harada N, Miyajima A.

J Biol Chem. 1993 Jul 25;268(21):15833-9.

37.
38.

GPA1Val-50 mutation in the mating-factor signaling pathway in Saccharomyces cerevisiae.

Miyajima I, Arai K, Matsumoto K.

Mol Cell Biol. 1989 Jun;9(6):2289-97.

39.

Suppressors of a gpa1 mutation cause sterility in Saccharomyces cerevisiae.

Miyajima I, Nakayama N, Nakafuku M, Kaziro Y, Arai K, Matsumoto K.

Genetics. 1988 Aug;119(4):797-804.

40.

Isolation of a second yeast Saccharomyces cerevisiae gene (GPA2) coding for guanine nucleotide-binding regulatory protein: studies on its structure and possible functions.

Nakafuku M, Obara T, Kaibuchi K, Miyajima I, Miyajima A, Itoh H, Nakamura S, Arai K, Matsumoto K, Kaziro Y.

Proc Natl Acad Sci U S A. 1988 Mar;85(5):1374-8.

41.

The role of G proteins in yeast signal transduction.

Matsumoto K, Nakafuku M, Nakayama N, Miyajima I, Kaibuchi K, Miyajima A, Brenner C, Arai K, Kaziro Y.

Cold Spring Harb Symp Quant Biol. 1988;53 Pt 2:567-75. No abstract available.

PMID:
2855496
42.

GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction.

Miyajima I, Nakafuku M, Nakayama N, Brenner C, Miyajima A, Kaibuchi K, Arai K, Kaziro Y, Matsumoto K.

Cell. 1987 Sep 25;50(7):1011-9.

PMID:
3113739
43.
44.

Analysis of full-length cDNA clones carrying GAL1 of Saccharomyces cerevisiae: a model system for cDNA expression.

Miyajima A, Nakayama N, Miyajima I, Arai N, Okayama H, Arai K.

Nucleic Acids Res. 1984 Aug 24;12(16):6397-414.

45.
46.

[Mother-child relations at delivery by cesarean section].

Shin A, Yamamoto A, Miyajima I, Usukura K.

Josanpu Zasshi. 1983 Jun;37(6):460-7. Japanese. No abstract available.

PMID:
6559903
47.

[Anatomy and clinical significance of the tympanic mucosal fold].

Miyajima I, Umezawa Y, Honda Y.

Nihon Jibiinkoka Gakkai Kaiho. 1978 Nov;81(11):1504-7. Japanese. No abstract available.

PMID:
731355
48.

[Clinical use of a new muscle relaxant, pancuronium bromide].

Muteki T, Motomatsu K, Miyajima I, Oara T, Nakamura T.

Geka Chiryo. 1972 Apr;26(4):451-7. Japanese. No abstract available.

PMID:
4262168
49.

[Evaluation of spinal anesthesia during the acceleration of abdominal pressure].

Tomimatsu Y, Muteki T, Miyajima I.

Masui. 1967 Mar;16(3):212-9. Japanese. No abstract available.

PMID:
6070793

Supplemental Content

Loading ...
Support Center